Scientific evidence classification · Phase 6A preserved + Phase 6B additions
PWWP Compounds
& Bioactivity
Explore experimentally studied preparations separately from deposited research ligands, buffers, ions and unresolved chemical evidence. Every role is source- and target-context specific.
Combined Phase 6A + Phase 6B denominators. These groups overlap; the 109 structurally source-tagged research ligands are unchanged. Deposited components and reagents are not automatically biochemical binders.
Evidence classification · exact source records
132 matching profiles
80 matching assay / association observations. Counts here are profiles, not unique assay events or deposited ligand instances; views overlap.
UNC6934
BI-9466
No source-curated measured assay in this context. Structural evidence is shown separately.
Bis-Tris
No source-curated measured assay in this context. Structural evidence is shown separately.
BPP
Measurements remain attached to the reported preparation.
compound 1 (de Freitas 2021)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 11 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 12 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 13 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 5 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
compound 6 (Collie 2025)
Unresolved preparation · individual modeled components do not inherit its potency.
compound 7 (Collie 2025)
Measurements remain attached to the reported preparation.
H4K20me3 peptide / trimethyllysine monomer
No source-curated measured assay in this context. Structural evidence is shown separately.
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
HS13
Source verification is pending.
Unresolved preparation · individual modeled components do not inherit its potency.
LLC0424
MR837 (3f)
MRT866
MS9715
Measurements remain attached to the reported preparation.
MS9715N
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
NbH10
Unresolved preparation · individual modeled components do not inherit its potency.
UNC7096
UNC7145
No source-curated measured assay in this context. Structural evidence is shown separately.
Measurements remain attached to the reported preparation.
UNC7753
Unresolved preparation · individual modeled components do not inherit its potency.
UNC8153
Measurements remain attached to the reported preparation.
UNC8269
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
UNC8325
Unresolved preparation · individual modeled components do not inherit its potency.
Measurements remain attached to the reported preparation.
UNC8587
No source-curated measured assay in this context. Structural evidence is shown separately.
Unresolved preparation · individual modeled components do not inherit its potency.
UNC8732
Measurements remain attached to the reported preparation.
UNC8884
No source-curated measured assay in this context. Structural evidence is shown separately.
Unresolved preparation · individual modeled components do not inherit its potency.
varenicline
Source SMILES and full InChIKey require reconciliation.
(1R)-N-methyl-1-(pyridin-4-yl)propan-1-amine
Source verification is pending.
(1S)-1-(1-phenyl-1H-1,2,3-triazol-4-yl)ethan-1-amine
No source-curated measured assay in this context. Structural evidence is shown separately.
(2,6-difluorophenyl)(pyrrolidin-1-yl)methanone
No source-curated measured assay in this context. Structural evidence is shown separately.
(2R)-1-(2-methyl-1H-imidazol-1-yl)propan-2-ol
No source-curated measured assay in this context. Structural evidence is shown separately.
Source SMILES and full InChIKey require reconciliation.
(2R)-1-(cyclohexylamino)propan-2-ol
Source verification is pending.
(2R)-2-ethyl-N,N-dimethylmorpholine-4-sulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
(2R)-2-phenylpropane-1-sulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
(2S)-1-[4-[[(3R)-1,1-bis(oxidanylidene)thiolan-3-yl]methyl-methyl-amino]-6-methyl-pyrimidin-2-yl]-N-methyl-pyrrolidine-2-carboxamide
No source-curated measured assay in this context. Structural evidence is shown separately.
(2S)-1-[4-[[(3S)-1,1-bis(oxidanylidene)thiolan-3-yl]methyl-methyl-amino]-6-methyl-pyrimidin-2-yl]-N-methyl-pyrrolidine-2-carboxamide
No source-curated measured assay in this context. Structural evidence is shown separately.
Source SMILES and full InChIKey require reconciliation.
(2S)-N-(5-ethyl-1,3,4-thiadiazol-2-yl)oxolane-2-carboxamide
Source verification is pending.
(2S,5R)-4-[(5-chloro-1,2,3-thiadiazol-4-yl)methyl]-2,5-dimethylmorpholine
No source-curated measured assay in this context. Structural evidence is shown separately.
(2~{S})-1-[2-hydroxyethyl-[(2~{S})-2-oxidanylpropyl]amino]propan-2-ol
No source-curated measured assay in this context. Structural evidence is shown separately.
(2~{S})-6-methyl-~{N}-propan-2-yl-heptan-2-amine
No source-curated measured assay in this context. Structural evidence is shown separately.
Source SMILES and full InChIKey require reconciliation.
(3R)-N-methyl-1-(pyridazin-3-yl)piperidin-3-amine
Source verification is pending.
(3S)-1-(methanesulfonyl)piperidine-3-carboxylic acid
No source-curated measured assay in this context. Structural evidence is shown separately.
(4-methylpiperazin-1-yl)[(2R)-oxolan-2-yl]methanone
No source-curated measured assay in this context. Structural evidence is shown separately.
(5S)-7-(pyrazin-2-yl)-2-oxa-7-azaspiro[4.4]nonane
No source-curated measured assay in this context. Structural evidence is shown separately.
(5~{R})-7-pyrazin-2-yl-2-oxa-7-azaspiro[4.4]nonane
No source-curated measured assay in this context. Structural evidence is shown separately.
(6R)-6-(3,5-dichlorophenyl)morpholin-3-one
No source-curated measured assay in this context. Structural evidence is shown separately.
(Z)-N-methyl-3-sulfanyl-prop-2-enamide
No source-curated measured assay in this context. Structural evidence is shown separately.
1-(1,4-diazepan-1-yl)ethan-1-one
No source-curated measured assay in this context. Structural evidence is shown separately.
1-(2-ethyl-1,3-thiazol-5-yl)-N-methylmethanamine
No source-curated measured assay in this context. Structural evidence is shown separately.
1-(5-{9-[(4-{2-[(2S,3R)-2-(3,5-dichloro-4-fluorophenyl)-5-oxomorpholin-3-yl]ethyl}piperazin-1-yl)methyl]-3-azaspiro[5.5]undecane-3-carbonyl}-2-methylphenyl)-1,3-diazinane-2,4-dione
No source-curated measured assay in this context. Structural evidence is shown separately.
1-(diphenylmethyl)azetidin-3-ol
No source-curated measured assay in this context. Structural evidence is shown separately.
1-(ethanesulfonyl)piperidine-4-carboxylic acid
No source-curated measured assay in this context. Structural evidence is shown separately.
1-(methanesulfonyl)piperidin-4-ol
No source-curated measured assay in this context. Structural evidence is shown separately.
1-(propan-2-yl)-1H-imidazole-4-sulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
1-[(1-methyl-1H-pyrazol-4-yl)methyl]piperazine
No source-curated measured assay in this context. Structural evidence is shown separately.
1-[(thiophen-3-yl)methyl]piperidin-4-ol
No source-curated measured assay in this context. Structural evidence is shown separately.
1-bromanyl-4-methylsulfonyl-benzene
No source-curated measured assay in this context. Structural evidence is shown separately.
1-cyclohexyl-N-methylmethanesulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
2-(2,2-dimethylpyrrolidin-1-yl)ethan-1-amine
No source-curated measured assay in this context. Structural evidence is shown separately.
2-(4-bromanylpyrazol-1-yl)-~{N}-cyclopropyl-~{N}-methyl-ethanamide
No source-curated measured assay in this context. Structural evidence is shown separately.
2-(4-fluorophenoxy)-1-(pyrrolidin-1-yl)ethan-1-one
No source-curated measured assay in this context. Structural evidence is shown separately.
Source SMILES and full InChIKey require reconciliation.
2-[(2S)-2-methylpiperidin-1-yl]ethan-1-amine
Source verification is pending.
2-[(~{E})-2-thiophen-2-ylethenyl]benzoic acid
No source-curated measured assay in this context. Structural evidence is shown separately.
2-[4-(propan-2-yl)piperazin-1-yl]pyrimidine
No source-curated measured assay in this context. Structural evidence is shown separately.
2-[methyl(pyridin-2-yl)amino]ethan-1-ol
No source-curated measured assay in this context. Structural evidence is shown separately.
2-bromo-4-fluoro-N,N-dimethylbenzamide
No source-curated measured assay in this context. Structural evidence is shown separately.
2-chloro-N-methylbenzene-1-sulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
2-methoxy-N-[(4-methylphenyl)methyl]acetamide
No source-curated measured assay in this context. Structural evidence is shown separately.
3,5-dimethyl-4-(1-methyl-5-pyridin-4-yl-imidazol-4-yl)-1,2-oxazole
No source-curated measured assay in this context. Structural evidence is shown separately.
3,5-dimethyl-4-(4-pyridin-4-yl-1~{H}-pyrazol-3-yl)-1,2-oxazole
No source-curated measured assay in this context. Structural evidence is shown separately.
3-[(2S)-1-(methanesulfonyl)pyrrolidin-2-yl]-5-methyl-1,2-oxazole
No source-curated measured assay in this context. Structural evidence is shown separately.
3-cyclohexyl-1-(morpholin-4-yl)propan-1-one
No source-curated measured assay in this context. Structural evidence is shown separately.
4-(3-methyl-5-phenyl-imidazol-4-yl)pyridine
No source-curated measured assay in this context. Structural evidence is shown separately.
4-(dipropylamino)butanenitrile
No source-curated measured assay in this context. Structural evidence is shown separately.
4-[(5-chloro-1,2,3-thiadiazol-4-yl)methyl]morpholine
No source-curated measured assay in this context. Structural evidence is shown separately.
4-[5-(7-fluoranylquinolin-4-yl)-1-methyl-imidazol-4-yl]-3,5-dimethyl-1,2-oxazole
No source-curated measured assay in this context. Structural evidence is shown separately.
4-[5-[4-(aminomethyl)-2,6-dimethoxy-phenyl]-3-methyl-imidazol-4-yl]benzenecarbonitrile
No source-curated measured assay in this context. Structural evidence is shown separately.
4-[[(5-bromanylpyridin-3-yl)methylamino]methyl]aniline
No source-curated measured assay in this context. Structural evidence is shown separately.
Source SMILES and full InChIKey require reconciliation.
4-[[cyclopropyl-[(~{Z})-2-methyl-4-(5-oxidanylidene-2~{H}-1,4-oxazin-3-yl)but-3-enoyl]amino]methyl]-~{N}-[3-[2-[[4-(hydroxymethyl)phenyl]carbonyl-methyl-amino]ethyl]phenyl]benzamide
Source verification is pending.
4-bromo-1H-pyrazole
No source-curated measured assay in this context. Structural evidence is shown separately.
4-IODOPYRAZOLE
No source-curated measured assay in this context. Structural evidence is shown separately.
4-methyl-3-[1-methyl-5-(3-oxidanylidene-4~{H}-1,4-benzoxazin-7-yl)imidazol-4-yl]-~{N}-phenyl-benzamide
No source-curated measured assay in this context. Structural evidence is shown separately.
5-[2-hydroxyethyl(propyl)amino]pentan-1-ol
No source-curated measured assay in this context. Structural evidence is shown separately.
5-bromanylpyrimidine
No source-curated measured assay in this context. Structural evidence is shown separately.
5-methyl-2-piperidin-4-yl-6-pyridin-4-yl-pyridazin-3-one
No source-curated measured assay in this context. Structural evidence is shown separately.
5-methyl-6-phenyl-2-piperidin-4-yl-pyridazin-3-one
No source-curated measured assay in this context. Structural evidence is shown separately.
6-dipropylamino-1-hexanol
No source-curated measured assay in this context. Structural evidence is shown separately.
6-methyl-2-[(3-methyl-1,2-oxazol-5-yl)methyl]pyridazin-3(2H)-one
No source-curated measured assay in this context. Structural evidence is shown separately.
6-methyl-N-{[(3S)-pyrrolidin-3-yl]methyl}pyridin-2-amine
No source-curated measured assay in this context. Structural evidence is shown separately.
7-[3-methyl-5-[2-methyl-5-[(pyridin-3-ylamino)methyl]phenyl]imidazol-4-yl]-4~{H}-1,4-benzoxazin-3-one
No source-curated measured assay in this context. Structural evidence is shown separately.
7-[5-methyl-3-[2-methyl-5-(piperidin-1-ylmethyl)phenyl]-1,2-oxazol-4-yl]-4~{H}-1,4-benzoxazin-3-one
No source-curated measured assay in this context. Structural evidence is shown separately.
[(2R)-2-methylpiperidin-1-yl](4-methyl-1,3-thiazol-5-yl)methanone
No source-curated measured assay in this context. Structural evidence is shown separately.
Source SMILES and full InChIKey require reconciliation.
[(3S)-1-(propan-2-yl)piperidin-3-yl]methanol
Source verification is pending.
[3,5-dimethyl-4-(1-methyl-5-pyridin-4-yl-imidazol-4-yl)phenyl]methanamine
No source-curated measured assay in this context. Structural evidence is shown separately.
[3-[(5-bromanylpyridin-3-yl)methylamino]phenyl]methanol
No source-curated measured assay in this context. Structural evidence is shown separately.
[4-methyl-6-(piperidin-1-yl)pyrimidin-2-yl]methanol
No source-curated measured assay in this context. Structural evidence is shown separately.
CHOLINE ION
No source-curated measured assay in this context. Structural evidence is shown separately.
Ethambutol
No source-curated measured assay in this context. Structural evidence is shown separately.
isoquinoline-3-carboxylic acid
No source-curated measured assay in this context. Structural evidence is shown separately.
N,N,3,5-tetramethyl-1H-pyrazole-4-sulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N,N-diethyl-2-methylbenzamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N,N-dimethylmorpholine-4-sulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N,N-dimethylpiperazine-1-carboxamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N,N-dimethylpyridine-3-sulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N-(2-fluorophenyl)ethanesulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N-(2-methoxyphenyl)-2-selanyl-benzamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N-(4-acetylphenyl)-2-(pyrrolidin-1-yl)acetamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N-[(1S)-1-(pyridin-3-yl)ethyl]cyclopropanamine
No source-curated measured assay in this context. Structural evidence is shown separately.
N-[(3R)-1,1-dioxo-1lambda~6~-thiolan-3-yl]-N-methyl-N'-propan-2-ylurea
No source-curated measured assay in this context. Structural evidence is shown separately.
N-[(3S)-piperidin-3-yl]benzamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N-[(piperidin-4-yl)methyl]methanesulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N-cycloheptyl-N-methylmethanesulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N-ethyl-2-fluoro-4-(methylsulfonyl)aniline
No source-curated measured assay in this context. Structural evidence is shown separately.
N-methyl-1-([1,2,4]triazolo[4,3-a]pyridin-3-yl)methanamine
No source-curated measured assay in this context. Structural evidence is shown separately.
N-methyl-2-(methylsulfonyl)aniline
No source-curated measured assay in this context. Structural evidence is shown separately.
N-methyl-3-oxo-N-(propan-2-yl)piperazine-1-sulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N-methyl-N-(pyridin-3-yl)acetamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N-methyl-N-[2-oxo-2-(piperidin-1-yl)ethyl]methanesulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N-{(1R)-1-[(4S)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl}acetamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N-{[(4R)-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridin-3-yl]methyl}propanamide
No source-curated measured assay in this context. Structural evidence is shown separately.
N1-(2-hydroxyethyl)-2-methyl-1,2-propanediamine
No source-curated measured assay in this context. Structural evidence is shown separately.
N~1~,N~1~,N~4~,N~4~-tetramethylpiperazine-1,4-dicarboxamide
No source-curated measured assay in this context. Structural evidence is shown separately.
Triisopropanolamine
No source-curated measured assay in this context. Structural evidence is shown separately.
~{N},~{N}-dimethyl-1~{H}-pyrazole-4-sulfonamide
No source-curated measured assay in this context. Structural evidence is shown separately.
~{N}-(3-azanyl-2-methyl-phenyl)propanamide
No source-curated measured assay in this context. Structural evidence is shown separately.
~{N}-(4-aminophenyl)-2-selanyl-benzamide
No source-curated measured assay in this context. Structural evidence is shown separately.
~{N}-(4-fluorophenyl)-2-pyrrolidin-1-yl-ethanamide
No source-curated measured assay in this context. Structural evidence is shown separately.
~{N}-cyclopropyl-~{N}-[[4-[[2-(6-oxidanylhexanoyl)-1~{H}-isoquinolin-6-yl]carbamoyl]phenyl]methyl]-3-oxidanylidene-4~{H}-1,4-benzoxazine-7-carboxamide
No source-curated measured assay in this context. Structural evidence is shown separately.
~{N}-methyl-1-pyridin-4-yl-methanamine
No source-curated measured assay in this context. Structural evidence is shown separately.